IIPLA News
Wednesday, May 13, 2026

UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP

The acquisition enhances UPM’s intellectual property rights in lignocellulosic biomass conversion, supporting its industrial-scale bio-based chemicals production in Europe.

IIPLA News Deskanonymous access0 articles left this week
UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP

UPM Kymmene Oyj announced on 13 May 2026 that it has entered into an agreement to acquire the intellectual property related to Avantium N.V.’s Ray Technology®. This technology encompasses a process for producing bio-based mono-ethylene glycol (MEG) and mono-propylene glycol (MPG) derived from plant-based sugars.

The transaction includes Avantium’s patent portfolio and invention disclosures associated with Ray Technology®. While the deal is not material in financial terms for UPM, its strategic importance lies in expanding UPM’s intellectual property position in the conversion of lignocellulosic biomass into bio-based glycols.

By acquiring this IP, UPM broadens the scope of its portfolio that safeguards biomass-to-glycols conversion pathways. This expansion adds flexibility for future process configurations as UPM continues to scale its bio-based chemicals business. Currently, UPM is commissioning its industrial-scale production at the Leuna biorefinery in Germany, which is the first of its kind to produce lignocellulosic biomass-based chemicals at scale.

UPM’s Chief Technology Officer and Executive Vice President of UPM Next Generation Renewables, Harald Dialer, emphasized the strategic value of the acquisition: "This acquisition is a focused step that strategically expands the scope of our IP portfolio in bio-based glycols and strengthens our freedom to operate as we scale the industrial production of renewable chemicals."

Dialer further noted that combining Avantium’s Ray Technology® patent estate with UPM’s existing platform broadens future process options and reinforces the premium market position UPM has established with its 100% UPM Bio PET™ product. He added, "This transaction confirms UPM's role as a frontrunner in building a competitive European industrial bioeconomy."

The acquisition aligns closely with Avantium, a recognized leader in renewable and circular polymer materials, supporting the rapid development of a strong industrial bioeconomy in Europe. The presence of multiple industrial options entering the market simultaneously is expected to accelerate scaling.

UPM Next Generation Renewables focuses on creating sustainable, wood-based alternatives to fossil raw materials. Its product range includes renewable glycols, lignin-based functional fillers, renewable diesel, and naphtha. With biorefineries in Lappeenranta, Finland, and Leuna, Germany, UPM scales high-quality, low-carbon solutions for textiles, packaging, plastics, transport fuels, and other applications.

The company aims to enable customers to reduce emissions, improve environmental performance, and accelerate the transition to a circular bioeconomy. UPM Next Generation Renewables supports brands, converters, and industries worldwide in achieving climate and sustainability targets confidently, envisioning a future where renewable materials and sustainable production become the norm.

UPM is a global material solutions company with a portfolio spanning renewable fibres, advanced materials, decarbonization solutions, and communication papers. The company employs approximately 15,100 people worldwide and reported annual sales of approximately €9.7 billion. UPM’s shares are listed on Nasdaq Helsinki Ltd.

Share This Article
Ready-to-post copy includes the article link.

UPM Expands Bio-Based Glycols Patent Portfolio with Acquisition of Avantium's Ray Technology® IP UPM has acquired the intellectual property rights to Avantium’s Ray Technology®, a process for producing bio-based mono-ethylene glycol (MEG) and mono-propylene glycol (MPG) from plant sugars. This strategic move broade... Read the full IIPLA article: https://iipla.org/news/upm-expands-bio-based-glycols-patent-portfolio-with-acquisition-of-avantium-s-ray-technology-ip

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Canadian IP Law Faces Uncertainty Over Ownership and Protection of AI-Generated Content

As Canadian companies increasingly rely on generative AI for creative and coding tasks, intellectual property lawyers warn of unresolved legal questions regarding ownership and copyright protection. Without clear Canadian precedents, businesses risk losing recourse if AI-generated works are copied. Experts emphasize t…

Tuesday, July 21, 2026
PatentsAfrica

Navigating Tax Implications of Cross-Border Intellectual Property Transfers in Africa

As African jurisdictions tighten tax rules on cross-border intellectual property (IP) transactions, companies must carefully consider local substance requirements, specific IP tax regimes, and anti-avoidance measures. Key examples include Mauritius’ substance rules, Kenya’s Significant Economic Presence (SEP) tax on I…

Tuesday, July 21, 2026